A phase II study of TFTD plus Bevacizumab in patients with unresectable advanced colorectal cancer
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
Interventions: TFTD: fixed dose Bevacizumab: fixed dose Primary outcome(s): Time to treatment failure Study Design: Single arm Non-randomized
创建时间：
2018-12-15
